These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 31129432

  • 1. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X, Shen C, Zhang X, Wu L, Chen J, Ma B, Wang Q, Sun P, Lan Y, Su C.
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [Abstract] [Full Text] [Related]

  • 3. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice.
    Yang X, Yang J, Chu Y, Wang J, Guan M, Zhu X, Xue Y, Zou H.
    PLoS One; 2013 Mar; 8(4):e62855. PubMed ID: 23638156
    [Abstract] [Full Text] [Related]

  • 4. Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3.
    Jang SG, Lee J, Hong SM, Song YS, Kim MJ, Kwok SK, Cho ML, Park SH.
    J Transl Med; 2021 Feb 25; 19(1):86. PubMed ID: 33632240
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 6. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 15; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 7. Prolactin Increases the Frequency of Follicular T Helper Cells with Enhanced IL21 Secretion and OX40 Expression in Lupus-Prone MRL/lpr Mice.
    Alemán-García YP, Vaquero-García RM, Flores-Fernández R, Fuentes-Pananá EM, Gorocica-Rosete P, Pizaña-Venegas A, Chávez-Sanchéz L, Blanco-Favela F, Legorreta-Haquet MV, Chávez-Rueda AK.
    J Immunol Res; 2021 Sep 15; 2021():6630715. PubMed ID: 33763492
    [Abstract] [Full Text] [Related]

  • 8. AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2-STAT3 signaling pathway.
    Zhang Y, Pan Y, Zhang P, Wang F, Han Y, Li K, Jiang W, Wang J, Luan Y, Xin Q.
    Immun Inflamm Dis; 2023 Jun 15; 11(6):e903. PubMed ID: 37382269
    [Abstract] [Full Text] [Related]

  • 9. Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target.
    He L, Liao W, Wang X, Wang L, Liang Q, Jiang L, Yi W, Luo S, Liu Y, Qiu X, Li Y, Liu J, Wu H, Zhao M, Long H, Lu Q.
    Rheumatology (Oxford); 2024 May 03; 63(6):1699-1709. PubMed ID: 37665721
    [Abstract] [Full Text] [Related]

  • 10. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M, Chen H, Qiu J, Yang HX, Zhang CY, Fei YY, Zhao LD, Zhou JX, Wang L, Wu QJ, Zhou YZ, Zhang W, Zhang FC, Zhang X, Lipsky PE.
    J Autoimmun; 2020 May 03; 109():102440. PubMed ID: 32201226
    [Abstract] [Full Text] [Related]

  • 11. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
    Jiang Y, Chen H, Lin J, Pan J, Shen Y, Li Q.
    Clin Exp Pharmacol Physiol; 2023 Dec 03; 50(12):936-943. PubMed ID: 37727880
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May 03; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug 15; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.